Wolfgang Hartmann Selected Research

Ossifying Fibroma

1/2019

Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfgang Hartmann Research Topics

Disease

92	Neoplasms (Cancer) 04/2024 - 02/2004
19	Ewing Sarcoma (Sarcoma, Ewing) 10/2023 - 11/2015
16	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 11/2011
8	Medulloblastoma 05/2015 - 04/2005
7	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2024 - 07/2013
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2017
7	Adenocarcinoma 03/2022 - 03/2012
6	Synovial Sarcoma (Synovioma) 01/2023 - 10/2011
6	Myxoid Liposarcoma 04/2022 - 11/2012
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 01/2015
5	Infarction (Infarctions) 06/2020 - 12/2016
4	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2015
3	Margins of Excision 04/2023 - 01/2020
3	Thrombosis (Thrombus) 11/2021 - 12/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2017
3	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2017
3	Prostatic Neoplasms (Prostate Cancer) 02/2018 - 01/2017
3	Glioma (Gliomas) 08/2012 - 02/2010
3	Hepatoblastoma 07/2009 - 02/2004
2	Rhabdomyosarcoma 01/2024 - 11/2011
2	Giant Cell Tumors (Giant Cell Tumor) 08/2023 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 01/2018
2	Carcinogenesis 06/2022 - 02/2015
2	Gardner Syndrome 01/2022 - 01/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 07/2017
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 10/2018 - 08/2018
2	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2015
2	Solitary Fibrous Tumors 01/2015 - 11/2011
2	Primitive Neuroectodermal Tumors (PNET) 07/2014 - 03/2011
2	Liposarcoma 12/2013 - 11/2012
2	Oxyphilic Adenoma (Oncocytoma) 02/2012 - 11/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2012 - 11/2010
2	Pain (Aches) 01/2008 - 05/2006
1	Hypoxia (Hypoxemia) 10/2023
1	Adenocarcinoma of Lung 04/2023
1	Infections 01/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	COVID-19 01/2023

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 05/2024 - 05/2006
13	Messenger RNA (mRNA)IBA 03/2022 - 09/2004
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2007
9	Transcription Factors (Transcription Factor)IBA 04/2023 - 02/2004
9	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 05/2007
7	AntigensIBA 04/2024 - 01/2017
7	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2017
6	Thromboplastin (Tissue Factor)IBA 10/2023 - 12/2016
6	Phosphotransferases (Kinase)IBA 06/2022 - 07/2009
5	CateninsIBA 01/2023 - 01/2013
5	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 07/2013
4	Small Interfering RNA (siRNA)IBA 12/2022 - 07/2012
4	LigandsIBA 01/2021 - 01/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2016
4	CD13 Antigens (Alanine Aminopeptidase)IBA 06/2020 - 01/2017
4	Cyclin D1IBA 08/2018 - 07/2009
4	Histones (Histone)IBA 01/2017 - 11/2010
3	ParaffinIBA 04/2024 - 05/2007
3	CytokinesIBA 04/2024 - 01/2022
3	Tumor Biomarkers (Tumor Markers)IBA 11/2021 - 11/2011
3	Circulating Tumor DNAIBA 11/2021 - 01/2020
3	HLA-G Antigens (HLA G)IBA 06/2021 - 01/2017
3	Keratins (Keratin)IBA 05/2021 - 02/2015
3	Decitabine FDA Link 01/2019 - 06/2012
3	Peptide Hydrolases (Proteases)FDA Link 11/2017 - 01/2015
3	Lysine (L-Lysine)FDA Link 02/2012 - 11/2010
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2011 - 05/2006
3	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 10/2011 - 05/2006
3	beta CateninIBA 08/2008 - 06/2005
2	Tyrosine Kinase InhibitorsIBA 04/2024 - 09/2021
2	Histone DemethylasesIBA 03/2024 - 11/2011
2	AcidsIBA 04/2023 - 01/2022
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2023 - 01/2022
2	Protamines (Protamine Sulfate)FDA Link 12/2022 - 01/2022
2	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 09/2018
2	Surface Antigens (Surface Antigen)IBA 10/2020 - 01/2019
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 07/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 01/2017
2	ZincIBA 11/2017 - 01/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2017 - 01/2017
2	MicroRNAs (MicroRNA)IBA 05/2015 - 11/2012
2	Microfilament Proteins (Actin Binding Proteins)IBA 01/2015 - 10/2007
2	Formaldehyde (Formol)FDA Link 01/2015 - 05/2007
2	tyrosine receptor (receptor, tyrosine)IBA 04/2013 - 07/2009
2	AntibodiesIBA 02/2012 - 03/2011
2	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 05/2009 - 10/2005
2	LuciferasesIBA 06/2005 - 02/2004
1	Interleukin-18 (Interleukin 18)IBA 04/2024
1	Zoledronic Acid (Zometa)FDA Link 10/2023
1	ElementsIBA 10/2023
1	Denosumab FDA Link 08/2023
1	Transcription Factor Pit-1 (Transcription Factor Pit 1)IBA 04/2023
1	protoporphyrin IXIBA 04/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	PH 797804IBA 01/2023
1	VX 702IBA 01/2023

Therapy/Procedure

35	Therapeutics 01/2024 - 01/2008
15	Drug Therapy (Chemotherapy) 11/2022 - 03/2012
7	Radiotherapy 07/2023 - 01/2018
2	Induction Chemotherapy 10/2023 - 01/2020
2	Photochemotherapy (Photodynamic Therapy) 04/2023 - 01/2022
2	Ligation 01/2015 - 07/2014